How Americans get their medicines is changing rapidly.
Today in Chicago, a16z's @JayRughani sits down with:
- Tanvi Patel, VP & GM of Amazon Pharmacy
- AJ Loiacono, CEO of @judihealth
- @Annie_m_collins, co-founder of Aradigm Health
To discuss what's actually changing, and
Backing bold entrepreneurs who are engineering biology and reimagining healthcare.
Joined September 2019
- Baylor Scott & White CEO Peter McCanna on where AI has the potential to bring efficiency to health systems today: “We have to circle back to [systems deployed before AI] and say how do we really super charge them and put the rocket fuel of AI into them?” “Our transfer center...
- Formation Bio CEO Ben Liu on overcoming adverse selection in clinical trials: “No one's willingly looking to get rid of a great drug. And so the reason why we play at this IND Phase 1 translational medicine juncture is because this is where we think the markets are most
- “What I observe is in most cases, people confuse motion and progress.” Josh Weiner of CVS Health on how to balance speed and caution in the healthcare space: “Just because I got a pilot off the ground in one month, by no means suggests I set up for success.” “ People don’t
- “One of the biggest unlocks in VC-backed tech was when companies started going full stack to challenge incumbents head-on (‘Challengers’), versus just building tools for incumbents (‘Enablers’).” Healthtech is now following the same path. While tools for incumbents still


